ALK Genomic Aberrations in NSCLC and Clinical Implications

被引：0
|
作者：
Hirsch, F. R. [1 ]
机构：
[1] Mt Sinai, New York, NY USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 11期
关键词：
Crizotinib; Ceritinib; Alectinib; Brigatinib; Lorlatinib; CHEMOTHERAPY; CRIZOTINIB;
D O I：
10.1016/j.jtho.2019.09.114
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
I.17
引用
收藏
页码：S1163 / S1164
页数：3
相关论文
共 50 条
  • [31] MPRIP-ALK, a Novel ALK Rearrangement That Responds to ALK Inhibition in NSCLC
    Fang, Wenfeng
    Gan, Jiadi
    Hong, Shaodong
    Lu, Feng
    Zhang, Li
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (07) : E148 - E151
  • [32] Clinical Implications of Variant ALK FISH Rearrangement Patterns
    Gao, Xin
    Sholl, Lynette M.
    Nishino, Mizuki
    Heng, Jennifer C.
    Jaenne, Pasi A.
    Oxnard, Geoffrey R.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (11) : 1648 - 1652
  • [33] Gross genomic aberrations in precancers: Clinical implications of a long-term follow-up study in oral erythroplakias
    Sudbo, J
    Kildal, W
    Johannessen, AC
    Koppang, HS
    Sudo, A
    Danielsen, HE
    Risberg, B
    Reith, A
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) : 456 - 462
  • [34] LUNG CANCER BIOMARKER 1 (ALK): ALK DIAGNOSTICS IN NSCLC
    Chung, Jin-Haeng
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S441 - S441
  • [35] Clinical implications of genetic aberrations in metastatic prostate cancer
    Reichert, Zachery R.
    McKay, Rana R.
    CURRENT OPINION IN UROLOGY, 2019, 29 (04) : 319 - 325
  • [36] Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care
    Casolino, Raffaella
    Corbo, Vincenzo
    Beer, Philip
    Hwang, Chang-il
    Paiella, Salvatore
    Silvestri, Valentina
    Ottini, Laura
    Biankin, Andrew V.
    CANCERS, 2022, 14 (13)
  • [37] Clinical characteristics of ALK plus NSCLC patients (pts) treated with crizotinib beyond disease progression (PD): Potential implications for management.
    Otterson, Gregory Alan
    Riely, Gregory J.
    Shaw, Alice Tsang
    Crino, Lucio
    Kim, Dong-Wan
    Martins, Renato
    Salgia, Ravi
    Zhou, Caicun
    Solomon, Benjamin J.
    Wilner, Keith D.
    Polli, Anna
    Tang, Yiyun
    Bartlett, Cynthia Huang
    Ou, Sai-Hong Ignatius
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] GENOMIC IMPRINTING AND ITS CLINICAL IMPLICATIONS
    HALL, JG
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (12): : 827 - 829
  • [39] Brigatinib Effective in ALK plus NSCLC
    Leslie, Mitch
    CANCER DISCOVERY, 2017, 7 (01) : 4 - 5
  • [40] Therapeutic Sequencing in ALK+ NSCLC
    Elsayed, Mei
    Christopoulos, Petros
    PHARMACEUTICALS, 2021, 14 (02) : 1 - 18
12345